SCHEMBL5711752

SCHEMBL5711752

CCOC(=O)C(Oc1ccccc1)C(=O)OCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.54
LMNA P02545 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
PIN1 Q13526 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
NPC1 O15118 2/20 0.50
ALDH1A1 P00352 3/20 0.48
TSHR P16473 2/20 0.48
MAPK1 P28482 1/20 0.48
MMP8 P22894 2/20 0.47
HPGD P15428 1/20 0.46
CRHBP P24387 1/20 0.46
RAB9A P51151 1/20 0.46
CRHR2 Q13324 1/20 0.46
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL855858 0.91 ALDH1A1 (0.54) TDP1LMNAL3MBTL1PIN1MEN1
SCHEMBL6959131 0.88 TDP1 (0.48) TDP1LMNAL3MBTL1PIN1MEN1
SCHEMBL29034853 0.87 CYP3A4 (0.45) TDP1LMNAL3MBTL1PIN1MEN1
SCHEMBL29034847 0.86 TDP1 (0.43) TDP1LMNAL3MBTL1PIN1MEN1
SCHEMBL11493984 0.85 TDP1 (0.54) TDP1LMNAL3MBTL1PIN1MEN1
SCHEMBL17901029 0.83 LMNA (0.72) TDP1LMNAL3MBTL1PIN1MEN1
SCHEMBL7329538 0.83 TAS1R3 (0.51) TDP1LMNAL3MBTL1MEN1KMT2A
SCHEMBL2805987 0.83 LMNA (0.72) TDP1LMNAL3MBTL1PIN1MEN1
SCHEMBL4237234 0.83 TDP1 (0.53) TDP1LMNAL3MBTL1PIN1MEN1
SCHEMBL7324340 0.82 ALDH1A1 (0.61) TDP1LMNAL3MBTL1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6206847-A None JP disclosed
EP-0582198-B1 Substituted (hetero-)aryle compounds, process for their preparation, those containing compositions and their use as safeners BAYER CROPSCIENCE GMBH (DE) 2006-02-08 EP disclosed
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
US-6482947-B1 Substituted (hetero) aryl compounds, process for their preparation, agents containing them and their use as safeners HOECHST AKTIENGESELLSCHAFT (DE) 2002-11-19 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed
US-5739079-A CEREAL, RICE, CORN CROP SAFENER MIXED WITH WEED HERBICIDE HOECHST AKTIENGESELLSCHAFT (DE) 1998-04-14 US disclosed
JP-H06206847-A SUBSTITUTED (HETERO)ARYL COMPOUND, ITS PREPARATION, CONTAINING IT AND THEIR USE AS SAFENER HOECHST AG 1994-07-26 JP disclosed
EP-0582198-A2 Substituted (hetero-)aryle compounds, process for their preparation, those containing compositions and their use as safeners Hoechst Schering AgrEvo GmbH (DE) 1994-02-09 EP disclosed
US-5273993-A Antiarthritic agents; osteoporosis A. H. ROBINS COMPANY, INCORPORATED (US) 1993-12-28 US disclosed
US-5194446-A Antiarthritic agents A. H. ROBINS COMPANY, INCORPORATED (US) 1993-03-16 US disclosed
US-5192785-A Sulfamates as antiglaucoma agents A. H. ROBINS COMPANY, INCORPORATED (US) 1993-03-09 US disclosed
US-5025031-A Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants A. H. ROBINS CO., INC. (US) 1991-06-18 US disclosed
EP-0403185-A2 Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals A.H. ROBINS COMPANY, INCORPORATED (US) 1990-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 TDP1 4224/4885LMNA 4239/4885L3MBTL1 1431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.